Literature DB >> 2153215

Cephalosporin 3'-quinolone esters with a dual mode of action.

H A Albrecht1, G Beskid, K K Chan, J G Christenson, R Cleeland, K H Deitcher, N H Georgopapadakou, D D Keith, D L Pruess, J Sepinwall.   

Abstract

According to the generally accepted mechanism by which bacterial enzymes react with cephalosporins, opening of the beta-lactam ring can lead to the expulsion of a 3'-substituent. A series of dual-action cephalosporins was prepared in which antibacterial quinolones were linked to the cephalosporin 3'-position through an ester bond in the expectation that, in addition to exerting their own beta-lactam activity, these cephalosporins would act as prodrugs for the second antibacterial agent. Compared to parent cephalosporins in which the 3'-substituent was acetoxy, the bifunctional cephalosporins exhibited a broadened antibacterial spectrum, suggesting that a dual mode of action may indeed be operative.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153215     DOI: 10.1021/jm00163a013

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

1.  A Hybrid Drug Limits Resistance by Evading the Action of the Multiple Antibiotic Resistance Pathway.

Authors:  Kathy K Wang; Laura K Stone; Tami D Lieberman; Michal Shavit; Timor Baasov; Roy Kishony
Journal:  Mol Biol Evol       Date:  2015-11-03       Impact factor: 16.240

2.  Dual-Pharmacophore Pyrithione-Containing Cephalosporins Kill Both Replicating and Nonreplicating Mycobacterium tuberculosis.

Authors:  Landys Lopez Quezada; Kelin Li; Stacey L McDonald; Quyen Nguyen; Andrew J Perkowski; Cameron W Pharr; Ben Gold; Julia Roberts; Kathrine McAulay; Kohta Saito; Selin Somersan Karakaya; Prisca Elis Javidnia; Esther Porras de Francisco; Manuel Marin Amieva; Sara Palomo Dı Az; Alfonso Mendoza Losana; Matthew Zimmerman; Hsin-Pin Ho Liang; Jun Zhang; Veronique Dartois; Stéphanie Sans; Sophie Lagrange; Laurent Goullieux; Christine Roubert; Carl Nathan; Jeffrey Aubé
Journal:  ACS Infect Dis       Date:  2019-06-11       Impact factor: 5.084

3.  Structure-activity studies of quinolone-penems in genetically defined strains of Escherichia coli.

Authors:  A F Ehrhardt; C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

Review 4.  Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?

Authors:  Ronald Domalaon; Temilolu Idowu; George G Zhanel; Frank Schweizer
Journal:  Clin Microbiol Rev       Date:  2018-03-14       Impact factor: 26.132

5.  Pharmacokinetics of Ro 23-9424, a dual-action cephalosporin, in animals.

Authors:  J G Christenson; K K Chan; R Cleeland; B Dix-Holzknecht; H H Farrish; I H Patel; A Specian
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

6.  Copper Influences the Antibacterial Outcomes of a β-Lactamase-Activated Prochelator against Drug-Resistant Bacteria.

Authors:  Jacqueline M Zaengle-Barone; Abigail C Jackson; David M Besse; Bradford Becken; Mehreen Arshad; Patrick C Seed; Katherine J Franz
Journal:  ACS Infect Dis       Date:  2018-03-26       Impact factor: 5.084

7.  Rapid point-of-care detection of the tuberculosis pathogen using a BlaC-specific fluorogenic probe.

Authors:  Hexin Xie; Joseph Mire; Ying Kong; MiHee Chang; Hany A Hassounah; Chris N Thornton; James C Sacchettini; Jeffrey D Cirillo; Jianghong Rao
Journal:  Nat Chem       Date:  2012-09-02       Impact factor: 24.427

8.  Mechanisms of action of cephalosporin 3'-quinolone esters, carbamates, and tertiary amines in Escherichia coli.

Authors:  N H Georgopapadakou; A Bertasso
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

9.  beta-Lactamase hydrolysis of cephalosporin 3'-quinolone esters, carbamates, and tertiary amines.

Authors:  N H Georgopapadakou; C McCaffrey
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

10.  Exploitation of Antibiotic Resistance as a Novel Drug Target: Development of a β-Lactamase-Activated Antibacterial Prodrug.

Authors:  Lindsay E Evans; Aishwarya Krishna; Yajing Ma; Thomas E Webb; Dominic C Marshall; Catherine L Tooke; James Spencer; Thomas B Clarke; Alan Armstrong; Andrew M Edwards
Journal:  J Med Chem       Date:  2019-05-01       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.